Inside Penn

In brief, what’s happening at Penn—whether it’s across campus or around the world.

Filter Stories

Displaying 31 - 40 of 1762
  • Child care gig workers are getting scammed. Why aren’t the platforms where scammers lurk doing more about it?

    Annenberg School for Communication professor Julia Ticona spoke to domestic gig workers about the scams they face on the platforms where they find work and how they help one another avoid them.

    FULL STORY AT Annenberg School for Communication

  • Can the U.S. embrace a four-day workweek?

    With the pandemic-fueled demand for more workplace flexibility, could the four-day workweek become the norm in American business? Wharton experts don’t hold out hope for change.

    FULL STORY AT Knowledge at Wharton

  • Scientists are on the trail of a treatment for traumatic memories

    A Penn study finds that inhibiting a key enzyme alleviates fear-memory behavior associated with traumatic memories, and maybe used to treat disorders such as PTSD.

    FULL STORY AT Penn Medicine News

  • Inflation Reduction Act includes fix for issues with Medicare Part D design first proposed by Penn team

    One key part of the Inflation Reduction Act is the section on the changes to the Medicare Part D prescription drug benefit design. This section fixes issues with the Medicare Part D design that were highlighted by a team at Penn led by professor of medicine and CHIBE associate director Jalpa Doshi.

    FULL STORY AT Center for Health Incentives and Behavioral Economics

  • A vision for addressing climate change through engineering research

    Vijay Kumar, Nemirovsky Family Dean of Penn Engineering, and Shu Yang, Joseph Bordogna Professor and Chair of the Department of Materials Science and Engineering, played critical roles in the development of a report from Engineering Research Visioning Alliance which delineates research priorities the engineering research community can pursue to address climate change.

    FULL STORY AT Penn Engineering Today

  • Penn Medicine awarded $5.7 Million NCI grant for new Cancer Telehealth Research Center of Excellence

    The funding will support clinical research of new telehealth methods for better cancer care, under the reignited White House Cancer Moonshot initiative.

    FULL STORY AT Penn Medicine News

  • Many adolescents face barriers to confidential reproductive health care

    A federal Title X program, which allows minors to consent for and access confidential family planning care and other reproductive services, can minimize the harmful effects of post-Roe health care. However, many clinics left the Title X program in 2019 following a rule change that required them to be physically and financially separate from abortion services and to not discuss or refer patients for abortions. A JAMA Network Open study by Penn LDI mapped Title X-funded clinics before and after the rule change and found a net loss of 1,249 clinics.

    FULL STORY AT Leonard Davis Institute

  • New transitional care clinical pathway improves health equity

    People with multiple chronic conditions require complex care management and often experience significant challenges when transitioning from hospital to home. An innovative clinical pathway developed by clinicians, community partners and researchers at Penn Nursing holds promise to improve health equity and support a growing population experiencing adverse outcomes resulting from complex chronic illness, poverty, and structural inequality.

    FULL STORY AT Penn Nursing News

  • Penn Dental Medicine welcomes Class of 2026 with annual White Coat Ceremony

    Penn Dental Medicine welcomed the Class of 2026 DMD students to the study of dental medicine at its annual White Coat Ceremony, held August 11 at Penn Live Arts. This annual tradition presents members of the incoming class with a white coat to declare their commitment to assume the responsibilities of the dental profession.

    FULL STORY AT Penn Dental Medicine

  • New drug shows promise against autoimmune skin disease

    Penn Medicine researchers have found that an experimental drug called litifilimab could be a powerful long-term treatment for cutaneous lupus erythematosus, a form of lupus that occurs in the skin.

    FULL STORY AT Penn Medicine News